Locations:
Search IconSearch

Can the Kidney Microbiome Influence Stone Formation?

First full characterization of kidney microbiome unlocks potential to prevent kidney stones

microscopy image of kidney stones

Scanning electron microscopy shows direct interaction of kidney-resident E. coli (left; yellow arrows) on typical crystal structures of calcium oxalate (CaOx) dihydrate crystals the bacteria made, which resemble kidney stones. On right, rod shaped Lactobacillus crispatus do not interact with crystals, and the few crystals generated do not resemble kidney stones.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Editor’s note: This article was originally published by Cleveland Clinic Lerner Research.

Cleveland Clinic researchers have found definitive proof of a kidney microbiome that influences renal health and kidney stone formation, demonstrating that the urinary tract is not sterile and low levels of bacteria are normal.

The Nature Communications publication describes the rigorous multi-pronged approach a team led by Aaron Miller, PhD, and José Agudelo, MD, used to identify and characterize the small bacterial community by combining preclinical, human and dish studies. They also identified certain bacteria within the microbiome that could promote or block kidney stone development and showed that antibiotic misuse (commonly associated with kidney stone development in a hospital setting) skewed the microbiome towards stone-promoting bacteria.

Dr. Miller hopes his team’s findings will help overturn the concept of a sterile urinary tract once and for all and lead to better prevention or treatment options for a condition that hasn’t seen major medical advances in over three decades.

“Urologic diseases like kidney stones impact 63% of the adult population and are getting worse,” he says.“The data consistently points towards bacteria. If we can’t get over the assumption of sterility, we can’t develop more effective treatments and preventative options.”

Is urine sterile? Investigating the urobiome

Normal bacteria levels in urine are very low, but they are rarely zero. Despite this, the urobiome – microbiome of different organs in the urinary tract including the bladder and kidneys – has been a controversial topic since its discovery in human urine less than 15 years ago.

Advertisement

First author and urologist José Agudelo, MD, had personally seen bacteria in the kidneys of his patients in the decade he spent treating patients in Venezuela. However, he explains that these observations and previous studies of a kidney microbiome gave compelling evidence but left enough room for doubt.

First author and urologist José Agudelo, MD, who has extensive experience in urinary stone disease, explains that previous indirect findings of a kidney microbiome gave compelling evidence but left room for doubt.

Bacterial communities need to meet three criteria to be considered a true microbiome: stability, consistency and reproducibility and being metabolically active. The team’s methods demonstrated each of these aspects for bacteria found in the urinary tract. Their research also showed that bacteria living in the urinary tract were not only there because of disease, since they found them in the urinary tract of people without evidence of urologic disease.

Other studies had shown that two species Drs. Miller and Agudelo had identified, E. coli and Lactobacillus crispatus, had been associated with the presence and absence of kidney stones, respectively. The researchers asked if the metabolic activity of their newly discovered microbial community played a role in kidney stone formation.

Low levels of Lactobacillus in urine, kidneys, are normal and prevent kidney stone formation

To see whether the kidney microbiome could influence stone formation, the researchers grew bacteria using a special chamber that mimics the movement of urine in our kidneys. They then added the “raw ingredients” of kidney stones, oxalate and calcium, to see what happened.

Advertisement

Several large, stone-like crystal structures formed in chambers growing E. coli. Chemical and X-ray analyses revealed these structures were indistinguishable from human kidney stones. No stones formed in the chambers growing Lactobacillus in this way. Growing the two bacteria together resulted in very small crystal structures that were structurally and chemically different from kidney stones, indicating that Lactobacillus somehow blocks E. coli’s ability to form kidney stones.

In preclinical models, the team also saw that antibiotic overuse shifted the balance of the kidney microbiome away from the healthy Lactobacillus towards the stone-forming E. coli. They believe their findings, taken together, may explain why individuals on long-term antibiotic courses are more prone to developing kidney stones.

“Antibiotics are one of – if not the – most miraculous inventions of the modern age, but they do not come without consequences,” Dr. MIller says. “Our findings about how antibiotics impact the renal microbiome and stone formation give us a critical piece of the puzzle we need to combat these consequences.”

Implications for kidney stones and other diseases

Dr. Agudelo says his team’s findings suggest that different bacteria produce pro- and anti- kidney stone molecules, which he wants to use in new therapeutic and diagnostic techniques. He is already working to understand which bacterial metabolites influence stone formation, and how.

“If the kidney microbiome can influence kidney stones, it can likely influence other kidney diseases as well,” Dr. Miller adds. “We are already looking at microbial signatures for other kidney diseases and have even submitted a grant to investigate how certain genetic variants influence the renal microbiome and kidney disease risk in different ethnicities.”

Advertisement

Advertisement

Related Articles

Illustration of gut microbes
December 23, 2024/Urology & Nephrology
Bladder Cancer: Optimizing Treatment Response Through the Gut Microbiome

Research program sets the stage for clinical trials

Closeup of bariatric surgery
November 18, 2024/Digestive/Research
Dramatic Microbiome Change Predicts Weight Loss Effectiveness After Metabolic Bariatric Surgery

Findings could help identify patients at risk for poor outcomes

gut microbes in the human intestine
Gut Microbial TMAO Pathway Associated With Incident Heart Failure

Metabolites from animal product substrates implicated in heart failure development in community cohorts

gut-brain axis
Assessing Alzheimer’s Disease Drug Targets Along the Gut-Brain Axis

Pairing machine learning with multi-omics revealed potential therapeutic targets

Kidney lithotripsy procedure Etracorporeal shock wave lithotripsy for remove
September 20, 2023/Urology & Nephrology/Research
Novel Approach Shows Efficacy in Fragmenting Kidney Stones

Cleveland Clinic is the first to investigate photonic nanoparticles as a potential kidney stone treatment

23-HVI-3853878_aortic-aneurysm_650x450
Study Identifies Gut Microbe-Derived TMAO as a Novel Mediator of Abdominal Aortic Aneurysm

Findings hold implications for screening and potential nonsurgical therapy

patient in ICU
Cleveland Clinic and Purdue Seek to Revolutionize Intensive Care Through AI

Investigators are developing a deep learning model to predict health outcomes in ICUs.

19-DDI-6059-IBD-CQD
Researchers Identify Promising Compound for IBD Treatment

Cleveland Clinic and Johns Hopkins collaboration could help meet need for new therapies

Ad